Stryker Corporation (SYK) — Analysis Summary
Stryker Corporation (SYK) has a market cap of $126.84B with year-over-year revenue growth of +11.2%. Net margin stands at 12.9%. The stock trades at a P/E ratio of 34.0.
Key Takeaways
- Revenue changed +11.2% year-over-year
- Net margin of 12.9%
- P/E ratio of 34.0
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, SYK posted revenue growth of +11.2% and trades at a P/E of 34.0.
Stryker Corporation (SYK)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, mechanical thrombectomy systems, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
56,000
Headquarters
PORTAGE, MI
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$3.52
Dividend Yield
1.06%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.